DUBLIN--(BUSINESS WIRE)--The "Global Pain Management Drugs Market Analysis 2018 - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
Assessment of major trends with potential impact on the market during the next eight years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis.
The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.
This report provides:
- Market Sizing estimations and forecasts across the given market segments
- Identifying market dynamics (Drivers, Restraints, Opportunities, Threats, Challenges and Opportunities)
- Strategic recommendations in key business segments based on the market estimations
- Regional and country level market analysis
- Competitive landscaping of major market players
- Company profiling covering the financials, recent activities and the future strategies
Key Topics Covered
1 Introduction
2 Executive Summary
3 Market Analysis
4 Porters Five Force Analysis
5 Pain Management Drugs Market by Category
6 Pain Management Drugs Market by Distribution Channel
7 Pain Management Drugs Market by Brands
8 Pain Management Drugs Market by Drug Class
9 Pain Management Drugs Market by Therapeutic Indications
10 Geographical Segmentation
11 Vendor Landscaping
12 Company Profiles
- Valeant Pharmaceuticals International Inc.
- Endo International PLC
- Johnson & Johnson
- Roche Holding AG
- GlaxoSmithKline PLC (GSK)
- Merck & Co. Inc.
- AstraZeneca PLC
- Pfizer Inc.
- Sanofi S.A.
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Eily, Lilly and Company
- Abbott Laboratories
- Purdue Pharma L.P.
- Novartis AG
- Baxter International Inc.
- Wex Pharmaceuticals Inc.
For more information about this report visit https://www.researchandmarkets.com/research/l6hxqj/global_pain?w=4
